During the last three months, 17 analysts shared their evaluations of Doximity (NYSE:DOCS), revealing diverse outlooks from bullish to bearish.

The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.

	Bullish	Somewhat Bullish	Indifferent	Somewhat Bearish	Bearish
Total Ratings	4	9	4	0	0
Last 30D	0	1	0	0	0
1M Ago	1	2	3	0	0
2M Ago	3	5	1	0	0
3M Ago	0	1	0	0	0

The 12-month price targets, analyzed by analysts, offer insights with an average target of $44.41, a high estimate of $65.00, and a low estimate of $33.00. Highlighting a 24.28% decrease, the current average has fallen from the previous average price target of $58.65.

Exploring Analyst Ratings: An In-Depth Overview

A clear picture of Doximity's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst	Analyst Firm	Action Taken	Rating	Current Price Target	Prior Price Target
Ryan Halsted	RBC Capital	Maintains	Outperform	$44.00	$44.00
Alexei Gogolev	JP Morgan	Lowers	Neutral	$33.00	$40.00
Jessica Tassan	Piper Sandler	Raises	Overweight	$42.00	$40.00
Glen Santangelo	Barclays	Lowers	Overweight	$38.00	$63.00
Steven Valiquette	Mizuho	Lowers	Neutral	$34.00	$45.00
Richard Close	Canaccord Genuity	Lowers	Buy	$34.00	$48.00
David Roman	Goldman Sachs	Lowers	Neutral	$34.00	$46.00
Jailendra Singh	Truist Securities	Lowers	Buy	$37.00	$62.00
Stan Berenshteyn	Wells Fargo	Lowers	Overweight	$45.00	$55.00
Jessica Tassan	Piper Sandler	Lowers	Overweight	$40.00	$70.00
Alexei Gogolev	JP Morgan	Lowers	Neutral	$40.00	$62.00
Ricky Goldwasser	Morgan Stanley	Lowers	Overweight	$49.00	$65.00
Ryan MacDonald	Needham	Lowers	Buy	$55.00	$75.00
David Larsen	BTIG	Lowers	Buy	$50.00	$80.00
Stan Berenshteyn	Wells Fargo	Lowers	Overweight	$55.00	$65.00
Scott Schoenhaus	Keybanc	Lowers	Overweight	$60.00	$75.00
Ricky Goldwasser	Morgan Stanley	Raises	Overweight	$65.00	$62.00

Key Insights:

• Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Doximity. This information provides a snapshot of how analysts perceive the current state of the company.
• Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Doximity compared to the broader market.
• Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Doximity's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.

Capture valuable insights into Doximity's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.

Stay up to date on Doximity analyst ratings.

Discovering Doximity: A Closer Look

Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.

Doximity: Financial Performance Dissected

Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.

Revenue Growth: Doximity displayed positive results in 3M. As of 31 December, 2025, the company achieved a solid revenue growth rate of approximately 9.76%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers.

Net Margin: Doximity's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 33.27% net margin, the company effectively manages costs and achieves strong profitability.

Return on Equity (ROE): Doximity's ROE stands out, surpassing industry averages. With an impressive ROE of 5.93%, the company demonstrates effective use of equity capital and strong financial performance.

Return on Assets (ROA): Doximity's ROA excels beyond industry benchmarks, reaching 5.1%. This signifies efficient management of assets and strong financial health.

Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.01.

Analyst Ratings: Simplified

Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.

Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.

This article was generated by Benzinga's automated content engine and reviewed by an editor.